Significant teratogenic and/or embryocidal effects have been demonstrated. Not to be taken by pregnant women and male partners of women who are pregnant. Take care to avoid pregnancy during therapy and for 6 months after completion of treatment in both female patients and female partners of male patients on ribavirin therapy. At least 2 reliable forms of effective contraception must be utilized during this period.
Subscribe to our mailing list to get the updates to your inbox